HPV prevalence and concordance in the cervix and oral cavity of pregnant women

Infectious Disease in Obstetrics and Gynecology

Volumn 12, Issue 2, 2004, Pages 45-56

  Smith, E M ^a,b   Ritchie, J M ^a   Yankowitz, J ^b   Wang, D ^a,c   Turek, L P ^b,c   Haugen, T H ^b,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Concordance; Genital; HPV; Oral cavity; Persistence; Pregnancy

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DELIVERY; DISEASE PREDISPOSITION; DNA SEQUENCE; DOT HYBRIDIZATION; FEMALE; GENITAL SYSTEM; GESTATION PERIOD; HUMAN; INOCULATION; MAJOR CLINICAL STUDY; MALE; MOUTH CAVITY; MUCOSA; OBSTETRIC CARE; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PRIORITY JOURNAL; QUESTIONNAIRE; UTERINE CERVIX; VIRUS DETECTION; VIRUS INFECTION; VIRUS ONCOGENE; VIRUS TRANSMISSION; VIRUS TYPING; WART VIRUS;

ADULT; CERVIX UTERI; DELIVERY, OBSTETRIC; DNA, VIRAL; FEMALE; HUMANS; IMMUNOBLOTTING; MALE; MOUTH; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; QUESTIONNAIRES; SEQUENCE ANALYSIS, DNA; SEXUAL PARTNERS; VAGINAL SMEARS;

EID: 10944223076     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1080/10647440400009896     Document Type: Article

References (45)

1. Walboomer JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19
2. Ho GY, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-71
3. Hildesheim A, Schiffman MH, Gravitt PE, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-40
4. Smith EM, Johnson SR, Gripe Pignatari S, Turek LP. Perinatal vertical transmission of human papillomavirus and subsequent development of respiratory tract papillomatosis. Ann Oto Rhinol Laryngo 1991;100:479-83
5. Smith EM, Johnson SR, Cripe T, et al. Perinatal transmission and maternal risks of human papillomavirus infection. Cancer Detect Prev 1995;19:196-205
6. Watts DH, Koutsky LA, Holmes KK, et al. Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. Am J Obstet Gynecol 1998;178:365-73
7. Schneider A, Hotz M, Gissmann L. Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer 1987;40:198-201
8. Smith EM, Hoffman HT, Summersgill KS, Kirchner HL, Turek LP, Haugen TH. Human papillomavirus and risk of oral cancer. Laryngoscope 1998;108:1098-103
9. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-20
10. Kelloski JK, Syrjanen SM, Chang F, Yliskoski M, Syrjanen KJ. Southern blot hybridization and PCR in detection of oral human papillomavirus (HPV) infections in women with genital HPV infections. J Oral Pathol Med 1992;21:1-6
11. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. JAMA 1989;262:931-4
12. Summersgill KS, Smith EM, Kirchner HL, Haugen TH, Turek LP. p53 polymorphism, human papillomavirus infection, and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:334-9
13. Chehab FF, Doherty M, Cai SP, Kan YW, Cooper S, Rubin EM. Detection of sickle cell anaemia and thalassaemias (letter). Nature 1987;329:293-4
14. Gravitt PE, Manos MM. Polymerase chain reaction-based methods for the detection of human papillomavirus DNA. IARC Sci Publ 1992;119:121-33
15. de Roda Husman A-M, Walboomers JM, van den Brule AJ, Meijers CL, Snijers PJ. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76:1057-62
16. Altschul SF, Madden TL, Schaeffer AA, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997;25:3389-402
17. SAS System for Windows. Version 8.2. Cary, NC: SAS Institute, 2001
18. Winer RL, Lee S-K, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003;157:218-26
19. Kellokoski JK, Syrjanen S, Yliskoski M, Syrjanen K. Dot blot hybridization in detection of human papillomavirus (HPV) infections in the oral cavity of women with genital HPV infections. Oral Microbiol Immunol 1992;7:19-23
20. Hippelainen MI, Yliskoski M, Syrjanen S, et al. Low concordance of genital human papillomavirus (HPV) lesions and viral types in HPV-infected women and their male sexual partners. Sex Trans Dis 1994;21:76-82
21. Brisson J, Bairati I, Morin C, et al. Determinants of persistent detection of human papillomavirus DNA in the uterine cervix. J Infect Dis 1996;173:794-99
22. Wallin K-L, Wiklund F, Angstrom T, et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999;341:1633-8
23. Wheeler CM, Greer CE, Becker TM, Hunt WC, Anderson SM, Manos MM. Short-term fluctuations in the detection of cervical human papillomavirus DNA. Obstet Gynecol 1996;88:261-8
24. Schneider A, Kirschhoff T, Meinhardt G, Gissmann L. Repeated evaluation of human papillomavirus 16 status in cervical swabs of young women with a history of normal papanicolaou smears. Obstet Gynecol 1992;79:683-8
25. Moscicki AB, Palefsky J, Smith G, Soboshski S, Schoolnik G. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol 1993;82:578-85
26. Ylitalo N, Sorensen P, Josefsson A, et al. Smoking and oral contraceptives as risk factors for cervical carcinoma in situ. Int J Cancer 1999;81:357-65
27. Lacey Jr JV, Brinton LA, Abbas FM, et al. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 1999;8:1079-85
28. Rando RF, Lindheim S, Hasty L, Sedlacek TV, Woodland M, Eder C. Increased frequency of detection of human papillomavirus deoxyribonucleic acid in exfoliated cervical cells during pregnancy. Am J Obstet Gynecol 1989;161:50-5
29. Morrison EA, Gammon MD, Goldberg GL, Vermund SH, Burk RD. Pregnancy and cervical infection with human papillomaviruses. Int J Gynaecol Obstet 1996;54:125-30
30. Shugars DC, Watkins CA, Cowen HJ. Salivary concentration of secretory leukocyte protease inhibitor, an antimicrobial protein, is decreased within advanced age. Gerontology 2001;47:246-53
31. Miletic ID, Schiffman SS, Miletic VD, Satterly-Miller EA. Salivary IgA secretion rate in young and elderly persons. Physiop Behav 1996;60:243-8
32. Steele C, Fidel Jr PL. Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun 2002;70:577-83
33. Chang-Claude J, Schneider A, Smith E, Blettner M, Wahrendorf J, Turek L. Longitudinal study of the effects of pregnancy and other factors on detection of HPV. Gynecol Oncol 1996;60:355-62
34. Kemp EA, Hakenwerth AM, Laurent SL, Everitt PE, Stoerker J. Human papillomavirus prevalence in pregnancy. Obstet Gynecol 1992;79:649-56
35. Smith EM, Johnson SR, Jiang D, et al. The association between pregnancy and human papillomavirus prevalence. Cancer Detect Prev 1991;15:397-402
36. Chan WK, Klock G, Bernard HU. Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. J Virol 1989;63:3261-9
37. Pater A, Bayatpour M, Pater MA. Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives. Am J Obstet Gynecol 1990;162:1099-103
38. Shneh S, Muller M, Schneider A, et al. Serologic response to the E4, E6, and E7 proteins of human papillomavirus type 16 in pregnant women. Am J Obstet Gynecol 1998;178:360-4
39. Veress G, Csiky-Mészâros T, Kónya J, Czeglédy J, Gergely L. Follow-up of human papillomavirus (HPV) DNA and local anti-HPV antibodies in cytologically normal pregnant women. Med Microbiol Immunol 1996;185:139-44
40. de Rosa Husman AM, Walboomers JM, Hopman E, et al. HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR: the age-related pattern. J Med Virol 1995;46:97-102
41. Baraggino E, Stinco G, Wiesenfeild U. Study of the partners of women with human papillomavirus infection. Int J Dermatol 1993;32:661-3
42. Barrasso R, DeBrux J, Croissant O, Orth G. High prevalence of papillomavirus-associated penile intraepithelial neoplasia in sexual partners of women with cervical intraepithelial neoplasia. N Engl J Med 1987;317:916-23
43. Bar-Am A, Niv J, Jaffo A, Jaffo A, Peyser RM. Prevalence of human papillomavirus infection and HPV DNA among male partners of Israeli women with genital premalignant and human papillomavirus lesions. Isr J Med Sci 1995;31:349-52
44. Maymon R, Bekerman A, Werchow M, Maymon BB, Segal R, Faktor JH. Clinical and subclinical condyloma. Rates among male sexual partners of women with genital human papillomavirus infection. J Reprod Med 1995;40:31-6
45. Wickenden C, Hanna N, Taylor-Robinson D, et al. Sexual transmission of human papillomaviruses in heterosexual and male homosexual couples, studied by DNA hybridization. Genitourinary Medicine 1988;64:34-8